retatrutide 3 receptors triple hormone receptor agonist mechanism of action Substack Series 6: – The Next Frontier in Longevity and Metabolic Health Retatrutide dose: the complete guide – PDB-101: Molecule of the Month:

Retatrutide falls between these at 28% despite delivering superior weight loss

I think at this point if the "standard of care" does not include a mandatory RT program (especially for older individuals), the doctors should be sued for malpractice

clinical biostimulator treatment becomes the right next step

GLP-1 medications are prescribed only after a medical evaluation and are used under ongoing physician supervision

[DOI] [PMC free article] [PubMed] [Google Scholar] [14].Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MT, Wadden TA, Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine 384(11) (2021) 9891002

GIP receptor agonism is hypothesised, based on preclinical and early clinical data, to complement GLP-1 effects on insulin secretion and may influence adipose tissue metabolism, though the precise contribution in humans remains an area of active investigation